Shandong Jincheng Pharmaceutical and Chemical Co Ltd Cash Flow Conversion Efficiency
Shandong Jincheng Pharmaceutical and Chemical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Shandong Jincheng Pharmaceutical and Chemical Co Ltd (300233) has a cash flow conversion efficiency ratio of 0.021x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥79.81 Million ≈ $11.68 Million USD) by net assets (CN¥3.72 Billion ≈ $543.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Shandong Jincheng Pharmaceutical and Chemical Co Ltd (2008–2025)
Cash flow conversion efficiency of Shandong Jincheng Pharmaceutical and Chemical Co Ltd from 2008 to 2025. This chart illustrates how Shandong Jincheng Pharmaceutical and Chemical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 300233 stock price for real-time trading data and today's change.
Shandong Jincheng Pharmaceutical and Chemical Co Ltd Cash Flow Conversion Ratio Explained
Shandong Jincheng Pharmaceutical and Chemical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Shandong Jincheng Pharmaceutical and Chemical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shandong Jincheng Pharmaceutical and Chemical Co Ltd ranked by their cash flow conversion efficiency. Also see 300233 company net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Jenkem Technology Co Ltd
SHG:688356
|
-0.013x |
|
Zee Entertainment Enterprises Limited
NSE:ZEEL
|
-0.002x |
|
Beijing Asiacom Information Technology Co.Ltd
SHE:301085
|
N/A |
|
Zhejiang Chunhui Intelligent Control Co. Ltd.
SHE:300943
|
-0.001x |
|
Suntar Environmental Technology Co
SHG:688101
|
0.012x |
|
Hunan Heshun Petroleum Co Ltd
SHG:603353
|
0.114x |
|
Carlton Investments Ltd
AU:CIN
|
0.025x |
|
Electronics Mart India Limited
NSE:EMIL
|
0.167x |
Annual Cash Flow Conversion Efficiency for Shandong Jincheng Pharmaceutical and Chemical Co Ltd (2008–2025)
The table below shows the annual cash flow conversion efficiency of Shandong Jincheng Pharmaceutical and Chemical Co Ltd from 2008 to 2025. Review how much free cash does Shandong Jincheng Pharmaceutical and Che generate to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥3.72 Billion ≈ $544.93 Million |
CN¥319.64 Million ≈ $46.77 Million |
0.086x | +10.90% |
| 2024-12-31 | CN¥3.83 Billion ≈ $560.76 Million |
CN¥296.59 Million ≈ $43.40 Million |
0.077x | -55.93% |
| 2023-12-31 | CN¥3.78 Billion ≈ $553.29 Million |
CN¥664.08 Million ≈ $97.18 Million |
0.176x | +151.42% |
| 2022-12-31 | CN¥3.66 Billion ≈ $535.47 Million |
CN¥255.63 Million ≈ $37.41 Million |
0.070x | -45.04% |
| 2021-12-31 | CN¥3.44 Billion ≈ $503.30 Million |
CN¥437.19 Million ≈ $63.97 Million |
0.127x | -19.30% |
| 2020-12-31 | CN¥3.47 Billion ≈ $507.37 Million |
CN¥546.13 Million ≈ $79.92 Million |
0.158x | +11.32% |
| 2019-12-31 | CN¥4.08 Billion ≈ $597.74 Million |
CN¥577.98 Million ≈ $84.58 Million |
0.141x | +64.24% |
| 2018-12-31 | CN¥4.09 Billion ≈ $598.21 Million |
CN¥352.20 Million ≈ $51.54 Million |
0.086x | +123.44% |
| 2017-12-31 | CN¥3.94 Billion ≈ $576.20 Million |
CN¥151.83 Million ≈ $22.22 Million |
0.039x | -75.98% |
| 2016-12-31 | CN¥1.50 Billion ≈ $220.11 Million |
CN¥241.48 Million ≈ $35.34 Million |
0.161x | +1.17% |
| 2015-12-31 | CN¥1.31 Billion ≈ $191.74 Million |
CN¥207.92 Million ≈ $30.42 Million |
0.159x | -19.26% |
| 2014-12-31 | CN¥1.12 Billion ≈ $163.40 Million |
CN¥219.46 Million ≈ $32.11 Million |
0.197x | +113.78% |
| 2013-12-31 | CN¥1.02 Billion ≈ $149.51 Million |
CN¥93.92 Million ≈ $13.74 Million |
0.092x | +3.55% |
| 2012-12-31 | CN¥975.57 Million ≈ $142.76 Million |
CN¥86.61 Million ≈ $12.67 Million |
0.089x | +35.78% |
| 2011-12-31 | CN¥958.84 Million ≈ $140.31 Million |
CN¥62.69 Million ≈ $9.17 Million |
0.065x | -77.42% |
| 2010-12-31 | CN¥375.33 Million ≈ $54.92 Million |
CN¥108.67 Million ≈ $15.90 Million |
0.290x | -22.83% |
| 2009-12-31 | CN¥281.53 Million ≈ $41.20 Million |
CN¥105.62 Million ≈ $15.46 Million |
0.375x | +168.69% |
| 2008-12-31 | CN¥216.49 Million ≈ $31.68 Million |
CN¥30.23 Million ≈ $4.42 Million |
0.140x | -- |
About Shandong Jincheng Pharmaceutical and Chemical Co Ltd
Shandong Jincheng Pharmaceutical Group Co., Ltd researches and develops, produces, markets, and sells Cephalosporin pharmaceutical intermediates in China and internationally. It offers medical intermediate, animal nutrition, health care, CMO, CDMO, pharmaceuticals, API, finished dosage, and fine chemicals. The company was founded in 2004 and is based in Zibo, China.